Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Diabetes Care|November 11, 2017
Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based StudySengwee Toh, Marsha E Reichman, David J Graham, et al.
JAMA Internal Medicine|February 28, 2022
Association Between Generic-to-Generic Levothyroxine Switching and Thyrotropin Levels Among US AdultsJuan P Brito, Yihong Deng, Joseph S Ross, et al.
Annals of the Rheumatic Diseases|November 17, 2012
Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonistDaniel H Solomon, Jeremy A Rassen, Bindee Kuriya, et al.
Urology|June 16, 2024
Suicide and Intentional Self-harm Among Older Men Treated With 5-Alpha Reductase Inhibitor or Alpha-blockers for Benign Prostatic HyperplasiaDinci Pennap, Andrew D Mosholder, Adebola Ajao, et al.
Pharmacoepidemiology and Drug Safety|May 30, 2014
Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare dataMonika Houstoun, Marsha E Reichman, David J Graham, et al.
Arthritis and Rheumatism|October 12, 2012
Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseasesKevin Haynes, Timothy Beukelman, Jeffrey R Curtis, et al.
Parkinsonism & Related Disorders|May 16, 2018
Entacapone and prostate cancer in Parkinson's disease patients: A large Veterans Affairs healthcare system studyJacqueline M Major, Diane Dong, Francesca Cunningham, et al.
JAMA Network Open|September 30, 2020
Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin LevelsJuan P Brito, Joseph S Ross, Lindsey Sangaralingham, et al.
Pharmacoepidemiology and Drug Safety|February 3, 2021
Trends in Erythropoiesis-stimulating agent use and blood transfusions for chemotherapy-induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycleAmarilys Vega, Rongmei Zhang, Hui-Lee Wong, et al.
American Journal of Preventive Medicine|June 14, 2025
Cannabis-related healthcare encounters among U.S. commercially insured adultsSilvia Perez-Vilar, Sruthi Adimadhyam, Jillian Burk, et al.
Pageof 18